Company intelligence
Abcam
About Abcam
At Abcam, we believe the scientific community goes further, faster when we go there together. And to keep on making ground-breaking discoveries, we need to work together in new ways. That’s why we’re constantly innovating to help scientists drive their research forward by providing products and solutions that play an essential role in fundamental research, drug discovery, diagnostic and therapeutic applications. We started with a simple mission: to provide the best biological reagents to life scientists worldwide. Today, we help 750,000 researchers in over 130 countries deliver faster breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders. Abcam is proud to be part of Danaher. Danaher is a global life sciences and diagnostics innovator committed to accelerating the power of science and technology to improve human health. Together, we partner with customers to solve their toughest challenges—with speed and certainty.
Verified activity
Signals from Abcam
5 published signals
Presence & Recognition
Abcam is hosting the next Digital Cell Cycle Club on October 13 featuring keynote speaker Rebecca Heald from UC Berkeley.
Reported by Abcam
Partnerships
Abcam expanded its collaboration with Genedata to bring Genedata Biologics across its global R&D organization to strengthen antibody development, enhance data connectivity, and support AI-enabled innovation.
Reported by Abcam
Presence & Recognition
Abcam held joint customer meetings with Danaher colleagues Nikki Carter, Devina Divekar, Emma Robertson, and Ioan Neaga.
Reported by Joe Butler
Presence & Recognition
Abcam is hosting a Research Conference in Boston on 14–15 September for Immunometabolism Across Organs.
Reported by Abcam
Presence & Recognition
Abcam is hosting the Brain Aging and Degeneration Conference on December 11-12, 2026, at Stanford University.
Reported by Abcam